
We remember most clearly the leaders that have inspired us and shared their wisdom, and we absorb key truths from …
PharmaSwiss is planning to build a brand new manufacturing unit in Belgrade, Serbia, to allow it to carry out end-to-end …
A 'liver czar' is to be brought into the Department of Health to develop and oversee an effective strategy to …
More than 100,000 products and 25 retail pharmacies in Stockholm will take part in a two-month anti-counterfeiting project run by …

DNA Healthcare Advertising has appointed Jamie Hooper as an account manager.In his new role Jamie will work on a number …
Barbara Britten has joined Pharmexx UK as a business developement director.She most recently worked at Actelion, where she held the …
The UK's swine flu vaccination programme began today with NHS hospitals offering the jabs to frontline healthcare workers and patients …
Lonza said it has elected not to proceed with a $460 million bid to buy Canadian contract manufacturing and development …
Syntaxin, a biopharmaceutical company developing novel biologic drugs that control cell secretion, has appointed Andrew Sandham executive chairman.This follows the …

French genome engineering company Cellectis has appointed Dr Sylvie Delassus senior vice president communications and a member of its executive …

Contract research organisation Quintiles has launched a website for people considering participating in clinical trials. The company hopes Clinicalresearch.com will …
GlaxoSmithKline’s Votrient has been approved in the US by the FDA to treat the most common form of kidney cancer.This …
The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …

Fishawack Communications has appointed Gail Flockhart managing director following a restructure of its board of directors.Gail has over two decades …
Just two years ago it cost $10m to sequence a human genome, now for $48,000 you can have a personal …
US regulator the FDA has approved GlaxoSmithKline's cervical cancer vaccine Cervarix, finally allowing the company to bring it to the …
A round-up of developments in the pharmaceutical manufacturing sector, with facility updates from Neopharma, Nextpharma and Arch Pharmalab and new …
Bristol-Myers Squibb and AstraZeneca’s long-awaited type II diabetes drug Onglyza has been launched in the UK, its first European market.Designed …

Athena has promoted Hannah Stacey to senior account manager. Hannah has played an integral role in Athena’s new business initiatives …